Garrido-Laguna I - Search Results

1

A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.

Hidalgo M, Garcia-Carbonero R, Lim KH, Messersmith WA, Garrido-Laguna I, Borazanci E, Lowy AM, Medina Rodriguez L, Laheru D, Salvador-Barbero B, Malumbres M, Shields DJ, Grossman JE, Huang X, Tammaro M, Martini JF, Yu Y, Kern K, Macarulla T. Hidalgo M, et al. Cancer Res Commun. 2022 Nov 2;2(11):1326-1333. doi: 10.1158/2767-9764.CRC-22-0072. eCollection 2022 Nov. Cancer Res Commun. 2022. PMID: 36970055 Free PMC article. Clinical Trial.

2

Novel therapeutic targets in non-small cell lung cancer.

Janku F, Garrido-Laguna I, Petruzelka LB, Stewart DJ, Kurzrock R. Janku F, et al. J Thorac Oncol. 2011 Sep;6(9):1601-12. doi: 10.1097/JTO.0b013e31822944b3. J Thorac Oncol. 2011. PMID: 21849857 Free article. Review.

3

MRI evaluation of breast cancer.

Garrido-Laguna I, Fernandez Hidalgo O, Garcia Foncillas J. Garrido-Laguna I, et al. N Engl J Med. 2007 Jul 12;357(2):191; author reply 193. doi: 10.1056/NEJMc071183. N Engl J Med. 2007. PMID: 17625133 No abstract available.

4

Ridaforolimus in advanced sarcomas: a leap forward or missed opportunity?

Garrido-Laguna I, Janku F. Garrido-Laguna I, et al. J Clin Oncol. 2012 Mar 10;30(8):892-3. doi: 10.1200/JCO.2011.40.6538. Epub 2012 Jan 30. J Clin Oncol. 2012. PMID: 22291080 No abstract available.

5

Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic.

Janku F, Tsimberidou AM, Wang X, Hong DS, Naing A, Gong J, Garrido-Laguna I, Parsons HA, Zinner RG, Kurzrock R. Janku F, et al. Oncologist. 2011;16(3):327-35. doi: 10.1634/theoncologist.2010-0308. Epub 2011 Feb 21. Oncologist. 2011. PMID: 21339262 Free PMC article.

6

Paraneoplastic opsoclonus associated with squamous cell carcinoma of the tongue.

Wynn D, Merriman J, Patel AB, Hitchcock YJ, Garrido-Laguna I, Renner D, Clardy SL. Wynn D, et al. Clin Neurol Neurosurg. 2016 Oct;149:11-4. doi: 10.1016/j.clineuro.2016.05.023. Epub 2016 Jul 14. Clin Neurol Neurosurg. 2016. PMID: 27450762 No abstract available.

7

KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors.

Garrido-Laguna I, Hong DS, Janku F, Nguyen LM, Falchook GS, Fu S, Wheler JJ, Luthra R, Naing A, Wang X, Kurzrock R. Garrido-Laguna I, et al. PLoS One. 2012;7(5):e38033. doi: 10.1371/journal.pone.0038033. Epub 2012 May 31. PLoS One. 2012. PMID: 22675430 Free PMC article.

8

PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.

Janku F, Wheler JJ, Westin SN, Moulder SL, Naing A, Tsimberidou AM, Fu S, Falchook GS, Hong DS, Garrido-Laguna I, Luthra R, Lee JJ, Lu KH, Kurzrock R. Janku F, et al. J Clin Oncol. 2012 Mar 10;30(8):777-82. doi: 10.1200/JCO.2011.36.1196. Epub 2012 Jan 23. J Clin Oncol. 2012. PMID: 22271473 Free PMC article.

9

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.

Janku F, Tsimberidou AM, Garrido-Laguna I, Wang X, Luthra R, Hong DS, Naing A, Falchook GS, Moroney JW, Piha-Paul SA, Wheler JJ, Moulder SL, Fu S, Kurzrock R. Janku F, et al. Mol Cancer Ther. 2011 Mar;10(3):558-65. doi: 10.1158/1535-7163.MCT-10-0994. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216929 Free PMC article.

10

Response of histiocytoses to imatinib mesylate: fire to ashes.

Janku F, Amin HM, Yang D, Garrido-Laguna I, Trent JC, Kurzrock R. Janku F, et al. J Clin Oncol. 2010 Nov 1;28(31):e633-6. doi: 10.1200/JCO.2010.29.9073. Epub 2010 Aug 23. J Clin Oncol. 2010. PMID: 20733125 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page